• HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR)

    Source: Buzz FX / 19 Nov 2024 08:36:09   America/New_York


    HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR) Written by MarketBeat November 19, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating reaffi
    Read more...
Share on,